Spyre Therapeutics, Inc. Quarterly Common Stock, Shares Authorized from Q4 2015 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
The maximum number of common shares permitted to be issued by an entity's charter and bylaws.
Summary
Spyre Therapeutics, Inc. quarterly Common Stock, Shares Authorized history and growth rate from Q4 2015 to Q3 2024.
  • Spyre Therapeutics, Inc. Common Stock, Shares Authorized for the quarter ending September 30, 2024 was 400M shares, a 1900% increase year-over-year.
Common Stock, Shares Authorized, Quarterly (shares)
Common Stock, Shares Authorized, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 400M +380M +1900% Sep 30, 2024 10-Q/A 2024-11-18
Q2 2024 400M -100M -20% Jun 30, 2024 10-Q/A 2024-11-18
Q1 2024 400M -100M -20% Mar 31, 2024 10-Q/A 2024-11-18
Q4 2023 400M +380M +1900% Dec 31, 2023 10-Q/A 2024-11-18
Q3 2023 20M -480M -96% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 500M 0 0% Jun 30, 2023 10-Q 2023-08-11
Q1 2023 500M 0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 20M -480M -96% Dec 31, 2022 10-K/A 2024-11-18
Q3 2022 500M 0 0% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 500M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 500M 0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 500M 0 0% Dec 31, 2021 10-K 2023-03-02
Q3 2021 500M 0 0% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 500M 0 0% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 500M 0 0% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 500M 0 0% Dec 31, 2020 10-K 2022-03-08
Q3 2020 500M 0 0% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 500M 0 0% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 500M 0 0% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 500M 0 0% Dec 31, 2019 10-K 2021-03-18
Q3 2019 500M 0 0% Sep 30, 2019 10-Q 2019-11-06
Q2 2019 500M 0 0% Jun 30, 2019 10-Q 2019-08-06
Q1 2019 500M 0 0% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 500M 0 0% Dec 31, 2018 10-K 2020-02-24
Q3 2018 500M 0 0% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 500M 0 0% Jun 30, 2018 10-Q 2018-08-09
Q1 2018 500M 0 0% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 500M 0 0% Dec 31, 2017 10-K 2019-03-07
Q3 2017 500M 0 0% Sep 30, 2017 10-Q 2017-11-07
Q2 2017 500M 0 0% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 500M +475M +1900% Mar 31, 2017 10-Q 2017-05-09
Q4 2016 500M +475M +1900% Dec 31, 2016 10-K 2018-03-13
Q3 2016 500M Sep 30, 2016 10-Q 2016-11-09
Q2 2016 500M Jun 30, 2016 10-Q 2016-08-09
Q1 2016 25M Mar 31, 2016 10-Q 2016-05-19
Q4 2015 25M Dec 31, 2015 10-K 2017-03-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.